Nerve block may cut opioid needs after hysterectomy
NCT ID NCT07046949
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a nerve block called the anterior quadratus lumborum block, given before surgery, can reduce pain and the need for opioids in women undergoing abdominal hysterectomy. 56 participants were randomly assigned to receive either the nerve block plus standard care or standard care alone. The researchers measured pain levels, opioid use, and recovery quality after surgery.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- anterior quadratus lumborum block (a nerve block injection)
- What this could lead to
- If it works, this could offer a way to reduce pain and opioid use after hysterectomy, leading to faster recovery.
- What could go wrong
- This is a small, completed trial with only 56 participants. The nerve block may not actually reduce pain or opioid needs, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
56 people
The number who actually took part.
- Started
-
Jul 2025
- Finished
-
Dec 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
40 to 55 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * patients with ASA status I-II * patients with symptomatic fibroids * patients scheduled for abdominl hysterectomy Exclusion Criteria: * refusal to participate in the study at any of its stages * ASA class ≥ III * body mass index \> 40 kg/m2 * use of opiate receptor agonists/antagonists before surgery * uncontrolled hypertension
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Uterine bleeding are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Yuri Semenyuk Rivne regional cinical hospital
Rivne, Rivne Oblast, 33007, Ukraine
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can hormone pills replace chemo for aggressive endometrial cancer?
- Can AI learn to spot endometriosis and fibroids on ultrasound?
- Can big data improve safety in gynecologic surgery?
- Can a Double-Wall bag stop leaks during keyhole fibroid surgery?
- Can watching videos before surgery calm nerves?
- A drug that may curb bleeding during fibroid surgery faces its first big test